180 related articles for article (PubMed ID: 2186763)
1. [Cerebral circulation and calcium antagonists].
Uematsu D; Fukuuchi Y
No To Shinkei; 1990 Jan; 42(1):17-31. PubMed ID: 2186763
[No Abstract] [Full Text] [Related]
2. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
Kyoi K; Utsumi S
Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
[No Abstract] [Full Text] [Related]
3. [Calcium antagonists and cerebrovascular circulation].
De Gregorio C
Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466
[No Abstract] [Full Text] [Related]
4. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
[TBL] [Abstract][Full Text] [Related]
5. [Calcium inhibitors: effects on cerebral blood flow and intracranial pressure].
Payen D; Lamer C; Raggueneau JL
Agressologie; 1989 Jun; 30(7):408-10. PubMed ID: 2817237
[TBL] [Abstract][Full Text] [Related]
6. [Cerebral protective effects by continuous administration of a calcium antagonist after canine global brain ischemia--change in cerebral blood flow and metabolism].
Ono K; Iwatsuki N; Obara S; Hashimoto Y
Masui; 1988 Jan; 37(1):23-8. PubMed ID: 3367498
[No Abstract] [Full Text] [Related]
7. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
8. [Cerebrovascular circulation and metabolism. Action of calcium overload blockers].
Fortschr Med Suppl; 1985; 8():10-1. PubMed ID: 2867017
[No Abstract] [Full Text] [Related]
9. [Brain protection must be simultaneously specific and complex. Versatile effect of certain calcium antagonists].
Fortschr Med Suppl; 1985; 8():18-9. PubMed ID: 2867022
[No Abstract] [Full Text] [Related]
10. [Calcium channel blockers and cerebral circulation].
Uematsu D; Fukuuchi Y
Nihon Rinsho; 1989 Aug; 47(8):1770-5. PubMed ID: 2585739
[No Abstract] [Full Text] [Related]
11. [Calcium antagonists in the therapy of cerebrovascular diseases].
Cosmi F
Clin Ter; 1985 Mar; 112(5):465-8. PubMed ID: 4017471
[No Abstract] [Full Text] [Related]
12. [Calcium, calcium antagonists and cerebral circulation].
Beketov AI; Gromova TM
Farmakol Toksikol; 1988; 51(2):103-7. PubMed ID: 2454201
[No Abstract] [Full Text] [Related]
13. [Calcium antagonists and cerebral circulation].
Bes A; Géraud G; Fabre N
Rev Prat; 1988 Nov; 38(27):1983-5. PubMed ID: 3206150
[No Abstract] [Full Text] [Related]
14. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
[TBL] [Abstract][Full Text] [Related]
15. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
Sood AK; Dua A; Mahajan A; Arora S
J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
[No Abstract] [Full Text] [Related]
16. Pathophysiology of the cerebral circulation.
Ravussin P; Bracco D
Acta Anaesthesiol Scand Suppl; 1997; 111():89-91. PubMed ID: 9420967
[No Abstract] [Full Text] [Related]
17. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death.
Szabo L; Hofmann HP
Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657
[TBL] [Abstract][Full Text] [Related]
18. [Therapy in the early stage of cerebral insufficiency. Clinical and technical possibilities for evaluating the vascular system].
Fortschr Med Suppl; 1986; 1():9-10. PubMed ID: 2868982
[No Abstract] [Full Text] [Related]
19. Prevention, treatment, and resuscitation of cerebral ischemia.
Illievich UM; Dumitrescu RV; Papousek A; Schreier H; Glaser C; Klimscha W
Acta Anaesthesiol Scand Suppl; 1997; 111():95-9. PubMed ID: 9420970
[No Abstract] [Full Text] [Related]
20. [The effect of vasoactive preparations on the systemic and cerebral hemodynamics and on the blood rheological properties in patients with cerebrovascular insufficiency with a background of an atherosclerotic lesion of the precerebral arteries].
Ishchenko MM; Shkrobot SI; Ostrovs'ka OS
Lik Sprava; 1994; (7-8):133-6. PubMed ID: 7900337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]